{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000340.3:c.109G>A",
          "cDNA Change": {
            "transcript": "NM_000340.3",
            "ref": "G",
            "alt": "A",
            "position": "109"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "E",
            "position": "37"
          },
          "Description in input context": "A missense mutation in the SNCA gene (c.109G>A, p.G37E) associated with Parkinson's disease"
        }
      ]
    },
    {
      "Gene": "TARDBP",
      "variants": [
        {
          "HGVS": "NM_032043.2:c.1055G>A",
          "cDNA Change": {
            "transcript": "NM_032043.2",
            "ref": "G",
            "alt": "A",
            "position": "1055"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "D",
            "position": "352"
          },
          "Description in input context": "A pathogenic variant in TARDBP (c.1055G>A, p.G352D) linked to amyotrophic lateral sclerosis (ALS)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005085"
  },
  "Experiment Method": [
    {
      "Assay Method": "Immunohistochemistry",
      "Material used": {
        "Material Source": "Patients Derived Material",
        "Material Name": "Postmortem brain tissue from Parkinson's disease patients",
        "Description": "Immunohistochemistry was performed on postmortem brain tissue from Parkinson's disease patients and healthy controls."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000340.3:c.109G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased alpha-synuclein aggregation observed in brain tissue with the p.G37E variant compared to controls."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Five biological replicates were analyzed from different patients."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each slide was analyzed in duplicate by two independent pathologists."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Tissue from patients with confirmed Parkinson's disease was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Tissue from healthy controls without neurological disease was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "2"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Chi-square test was used to compare aggregation levels between groups."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Alpha-synuclein aggregation below 20% of total protein",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Alpha-synuclein aggregation above 50% of total protein",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293 cells overexpressing mutant TARDBP",
        "Description": "HEK293 cells were transfected with plasmids expressing wild-type or mutant TARDBP."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_032043.2:c.1055G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "Reduced TARDBP protein stability and increased cleavage fragments in cells with the p.G352D variant."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were conducted across different transfection experiments."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each gel was run in triplicate with three independent protein extractions."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type TARDBP overexpression was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector transfection was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "One-way ANOVA with post-hoc Tukey's test was used to compare protein levels."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "TARDBP protein levels within 10% of wild-type controls",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "TARDBP protein levels below 30% of wild-type controls",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}